MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

INMD — InMode Ltd. Ordinary Shares

Nasdaq

InMode Ltd. Ordinary Shares

CompareBack to Screener
$14.09
+0.04(+0.28%)
O
14.06
H
14.15
L
13.99
V
616.31K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About INMD

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

IndustryCommon Stock
SectorNot available
IPO DateAug 8, 2019
Employees660
Stock ExchangeNasdaq
Ticker SymbolINMD

Key Financial Statistics

Market Cap$810.80M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$12.72 - $16.74
52-Week Avg Volume777.2K
VWAP$14.07
Transactions6,456
Total Recorded Bars1,798 days